Structure |
Chemical Name |
CAS |
MF |
|
FeBuxostat Impurity 32 |
1805770-41-5 |
C12H12N2O |
|
Edoxaban Impurity 9(1R,2S,4S) |
2024614-15-9 |
C21H30ClN5O5 |
|
Rivaroxaban Impurity 22 |
1350288-77-5 |
C19H18ClN3O5S |
|
Rivaroxaban Impurity 27 |
1369969-44-7 |
C21H21N3O5 |
|
Abiraterone Impurity 9 |
165334-72-5 |
C24H31NO |
|
Gliclazide Impurity A |
|
|
|
Medetomidine Impurity 14 |
79924-14-4 |
C13H16N2 |
|
Tenofovir Disoproxil Impurity B |
36817-69-3 |
C8H11N5O |
|
Ipragliflozin IMP |
|
|
|
2-Propanone, 1,3-bis(4-methoxyphenyl)- |
29903-09-1 |
C17H18O3 |
|
1-NaphthaleneMethanaMine, α-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (αR)- |
1229512-52-0 |
C20H18F3N |
|
Benzoic acid, 2-[[[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]aMino]carbonyl]- |
1365267-37-3 |
C22H21N3O7 |
|
NSC 609249 |
51012-67-0 |
C12H20ClNO2 |
|
1-[(4-Ethoxy-3-formylphenyl)sulfonyl]-4-methylpiperazine |
332374-42-2 |
C14H20N2O4S |
|
ApovincaMinic Acid Ethyl Ester N-Oxide |
109741-24-4 |
C22H26N2O3 |
|
(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate |
752174-62-2 |
C20H25NO2 |
|
EMpagliflozin iMpurity 12 |
|
|
|
(2S,4R)-Teneligliptin |
1404559-15-4 |
C22H30N6OS |
|
Daclatasvir Impurity |
1417333-83-5 |
C40H50N8O6 |
|
(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole |
65576-39-8 |
C17H17NO |
|
1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine |
1293489-74-3 |
C18H22N2S |
|
N-acetyl-N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetaMide |
1379005-34-1 |
C17H19NO3 |
|
carfilzoMib iMpurity -A |
|
|
|
(3S,4R)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1593543-00-0 |
C24H21F2NO3 |
|
ethyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-N-pentanoyl-L-valinate |
1111177-30-0 |
C26H33N5O3 |
|
Rosuvastatin EP impurity A |
1714147-50-8 |
C25H34FN3NaO7S* |
|
Doxorubicin Impurity 6 |
69429-21-6 |
C26H27NO11 |
|
Etoricoxib Impurity 11 |
202409-31-2 |
C17H13ClN2O2S |
|
Levofloxacin Tetrafluoro Impurity 1 |
110548-02-2 |
C15H15F4NO4 |
|
Penicillin F Potassium Salt |
97299-13-3 |
C14H21KN2O4S |
|
Olaparib Impurity 31 |
458535-34-7 |
C12H18N2O2 |
|
Macitentan impurity A |
441798-25-0 |
C17H16Br2N6O4S |
|
4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE OXIME |
152642-35-8 |
C16H13Cl2NO |
|
3-Pyridinecarboxylic acid, 6-(4-carboxy-1-piperidinyl)-5-chloro- |
958457-83-5 |
C12H13ClN2O4 |
|
Linagliptin Impurity C |
|
|
|
Parecoxib Impurity B |
|
|
|
Vildagliptin impurity E |
|
|
|
3-propylisobenzofuran-1(3H)-one |
72424-08-9 |
C11H12O2 |
|
Axitinib Sulfonyl |
1348536-59-3 |
C22H18N4O3S |
|
Atracurium Impurity B |
87046-74-0 |
|
|
(R)-4-fluoro-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H24FN7O4 |
|
2-(2-fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(4H-1,2,4-triazol-4-yl)propan-2-ol |
|
C13H13FN6O |
|
Dapagliflozin Impurity 10 |
960404-86-8 |
C21H25ClO7 |
|
Ibrutinib Impurity 6 |
1917333-91-5 |
C28H26N6O3 |
|
Imatinib Impurity 5 |
|
|
|
Mirabegron Impurity 8 HCl |
1684452-81-0 |
C21H24N4O2S |
|
Regorafenib Impurity 2 |
|
|
|
Vonoprazan Impurity 5 |
|
|
|
Bendamustine |
1219709-86-0 |
C14H18ClN3O2 |
|
Dapagliflozin Impurity E |
|
|
|
Febuxostat Impurity 14 |
1335202-60-2 |
C15H16N2OS |
|
Kaempferol 3-robinoside 7-glucoside |
114924-89-9 |
C33H40O20 |
|
Vitexin 7-glucoside |
35109-95-6 |
C27H30O15 |
|
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one |
1367369-77-4 |
C12H15N5O3 |
|
2-chloromethyl-4-(3-hydroxypropoxy)-3-methylpyridine |
117976-92-8 |
C10H14ClNO2 |
|
8-Methoxy Entecavir |
2203740-23-0 |
C13H17N5O4 |
|
Bortezomib Impurity 32 |
1310383-72-2 |
C17H31BF3NO5 |
|
Topiroxostat Impurity 14 |
|
|
|
1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)- |
401564-34-9 |
C13H22N2O4S |
|
1616710-52-1 |
1616710-52-1 |
C27H34N2O6 |
|
6-HYDROXY ONDANSETRON |
110708-17-3 |
C18H19N3O2 |
|
8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one |
31251-41-9 |
C14H10ClNO |
|
(R)-Ornidazole |
166734-80-1 |
C7H10ClN3O3 |
|
Bendamustine Related Impurity 22 |
|
|
|
Bendamustine Related Impurity 9 |
|
|
|
Edoxaban Impurity 20 (1R,2R,4S) |
1928729-31-0 |
C16H29N3O7 |
|
Edoxaban Impurity 40 |
2081883-52-3 |
C14H27N3O3 |
|
Everolimus Impurity 2 |
|
|
|
Levosimendan Impurity 2 (Mixture ofZandEIsomers) |
|
|
|
N-(2,3-Dichloro-phenyl)-N'-[2-(2,3-dichloro-phenylamino)-ethyl]-ethane-1,2-diamine |
|
C16H17Cl4N3 |
|
Solifenacin Related Compound 29 |
861998-77-8 |
C23H26N2O3 |
|
Ticagrelor Impurity 31 |
|
|
|
Ticagrelor Related Compound 46 |
2205903-73-5 |
C28H42ClN9O8S2 |
|
Ticagrelor Related Compound 71 |
1548397-10-9 |
C7H8ClN3O3S |
|
Ticagrelor Related Compound 76 |
|
|
|
Vonoprazan Impurity 25 |
|
|
|
1-(3,4-Dimethoxyphenyl)-2-(methylsulfonyl)ethan-1-amine |
1255909-25-1 |
C11H17NO4S |
|
Adefovir Impurity C |
|
|
|
Blonanserin Impurity M |
|
|
|
Brexpiprazole Impurity H |
|
|
|
Cefaclor EP Impurity H |
|
|
|
Flupentixol Impurity B |
|
|
|
Ipratropium Bromide Impurity J |
|
C20H29Br2NO3 |
|
Apixaban Impurity 22 |
1449510-64-8 |
C25H26ClN5O4 |
|
Cefdinir impurity TU mixture |
|
|
|
Fotagliptin Impurity 1 |
|
|
|
Rocuronium bromide Impurity 7 |
|
|
|
Tofacitinib Impurity 69 |
|
|
|
Benzenamine, 3-(2-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)- |
641571-06-4 |
C11H10F3N3 |
|
Ciprofloxacin EP Impurity E |
879005-96-6 |
C16H20FN3O |
|
ethyl 2-(3-cyano-4-propoxyphenyl)-4-methylthiazole-5-
carboxylate |
|
C17H18N2O3S |
|
(2S,5R,6S)-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Diphenylmethyl Ester |
74189-25-6 |
C21H20BrNO3S |
|
Trelagliptin Impurity 5 |
2087874-92-6 |
C22H24FN5O5 |
|
9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-methoxy- |
51742-84-8 |
C11H15N5O5 |
|
2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid 1-oxide |
2418591-42-9 |
C16H16N2O4S |
|
Ropivacaine impurity |
1786841-18-6 |
C12H14N2O3 |
|
PREDNICARBATE RELATED COMPOUND A (20 MG) (1,2-DIHYDROPREDNICARBATE) |
671225-26-6 |
C27H38O8 |
|
OPEN RING AZTREONAM |
87500-74-1 |
C13H19N5O9S2 |
|
Carfilzomib Impurity B |
|
|
|
Ornidazole Impurity 1 |
1100750-18-2 |
|